TABLE OF CONTENTS
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5. GLOBAL NANO THERAPY MARKET, BY TECHNOLOGY
5.1 NANOMATERIAL AND BIOLOGICAL DEVICE
5.2 NANO ELECTRONIC BIOSENSOR
5.3 MOLECULAR NANOTECHNOLOGY
5.4 IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
5.5 OTHER
6. GLOBAL NANO THERAPY MARKET, BY APPLICATION
6.1 CARDIOVASCULAR DISEASE
6.2 CANCER THERAPY
6.3 DIABETES TREATMENT
6.4 RHEUMATOID ARTHRITIS
6.5 OTHER
7. GLOBAL NANO THERAPY MARKET, BY END USERS
7.1 HOSPITAL
7.2 CLINICS
7.3 RESEARCH LABORATORIES
8. GLOBAL NANO THERAPY MARKET, BY REGION
8.1 INTRODUCTION
8.2 AMERICA
8.2.1 NORTH AMERICA
8.2.1.1 US
8.2.1.2 CANADA
8.2.2 SOUTH AMERICA
8.3 EUROPE
8.3.1 WESTERN EUROPE
8.3.1.1 GERMANY
8.3.1.2 FRANCE
8.3.1.3 ITALY
8.3.1.3 SPAIN
8.3.1.5 UK
8.3.1.6 REST OF WESTERN EUROPE
8.3.2 EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 JAPAN
8.4.2 CHINA
8.4.3 INDIA
8.4.4 AUSTRALIA
8.4.5 REPUBLIC OF KOREA
8.4.6 REST OF ASIA-PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 UNITED ARAB EMIRATES
8.5.2 SAUDI ARABIA
8.5.3 OMAN
8.5.4 KUWAIT
8.5.5 QATAR
8.5.6 REST OF THE MIDDLE EAST & AFRICA
9. COMPETITIVE LANDSCAPE
9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
9.1.1 STRATEGIC PARTNERSHIP
9.1.2 MERGER & ACQUISITION
10 COMPANY PROFILE
10.1 NANOPROBES, INC
10.1.1 OVERVIEW
10.1.2 PRODUCT OVERVIEW
10.1.3 FINANCIALS
10.1.4 KEY DEVELOPMENTS
10.2 NANOSPECTRA BIOSCIENCES, INC
10.2.1 OVERVIEW
10.2.2 PRODUCT OVERVIEW
10.2.3 FINANCIALS
10.2.4 KEY DEVELOPMENTS
10.3 PARVUS THERAPEUTICS
10.3.1 OVERVIEW
10.3.2 PRODUCT OVERVIEW
10.3.3 FINANCIALS
10.3.4 KEY DEVELOPMENT
10.4 SMITH AND NEPHEW
10.4.1 OVERVIEW
10.4.2 PRODUCT OVERVIEW
10.4.3 FINANCIALS
10.4.4 KEY DEVELOPMENTS
10.5 SELECTA BIOSCIENCES, INC.
10.5.1 OVERVIEW
10.5.2 PRODUCT OVERVIEW
10.5.3 FINANCIALS
10.5.4 KEY DEVELOPMENTS
10.6 SIRNAOMICS, INC.
10.6.1 OVERVIEW
10.6.2 PRODUCT OVERVIEW
10.6.3 FINANCIALS
10.6.4 KEY DEVELOPMENTS
10.7 TARVEDA THERAPEUTICS
10.7.1 OVERVIEW
10.7.2 PRODUCT OVERVIEW
10.7.3 FINANCIALS
10.7.4 KEY DEVELOPMENTS
10.8 SIRNAOMICS, INC
10.8.1 OVERVIEW
10.8.2 PRODUCT OVERVIEW
10.8.3 FINANCIALS
10.8.4 KEY DEVELOPMENT
10.9 OTHERS
11 CONCLUSION
11.1 KEY FINDINGS
11.1.1 FROM CEO’S VIEWPOINT
11.1.2 UNMET NEEDS OF THE MARKET
11.2 KEY COMPANIES TO WATCH
11.3 PREDICTION OF NANOTECHNOLOGY INDUSTRIES
12 APPENDIX
LIST OF TABLES
Table 1 Nano Therapy Industry Synopsis, 2020-2027
Table 2 Global Nano Therapy Market Estimates and Forecast, 2020-2027, (USD Million)
Table 3 Global Nano Therapy Market by Region, 2020-2027, (USD Million)
Table 4 Global Nano Therapy Market by Technology, 2020-2027, (USD Million)
Table 5 Global Nano Therapy Market by Application, 2020-2027, (USD Million)
Table 6 Global Nano Therapy Market by End Users, 2020-2027, (USD Million)
Table 7 North America Nano Therapy Market by Technology, 2020-2027, (USD Million)
Table 8 North America Nano Therapy Market by Application, 2020-2027, (USD Million)
Table 9 North America Nano Therapy Market by End User, 2020-2027, (USD Million)
Table 10 US Nano Therapy Market by Technology, 2020-2027, (USD Million)
Table 11 US Nano Therapy Market by Application, 2020-2027, (USD Million)
Table 12 US Nano Therapy Market by End User, 2020-2027, (USD Million)
Table 13 Canada Nano Therapy Market by Technology, 2020-2027, (USD Million)
Table 14 Canada Nano Therapy Market by Application, 2020-2027, (USD Million)
Table 15 Canada Nano Therapy Market by End User, 2020-2027, (USD Million)
Table 16 South America Nano Therapy Market by Technology, 2020-2027, (USD Million)
Table 17 South America Nano Therapy Market by Application, 2020-2027, (USD Million)
Table 18 South America Nano Therapy Market by End User, 2020-2027, (USD Million)
Table 19 Europe Nano Therapy Market by Technology, 2020-2027, (USD Million)
Table 20 Europe Nano Therapy Market by Application, 2020-2027, (USD Million)
Table 21 Europe Nano Therapy Market by End User, 2020-2027, (USD Million)
Table 22 Western Europe Nano Therapy Market by Technology, 2020-2027, (USD Million)
Table 23 Western Europe Nano Therapy Market by Application, 2020-2027, (USD Million)
Table 24 Western Europe Nano Therapy Market by End User, 2020-2027, (USD Million)
Table 25 Eastern Europe Nano Therapy Market by Technology, 2020-2027, (USD Million)
Table 26 Eastern Europe Nano Therapy Market by Application, 2020-2027, (USD Million)
Table 27 Eastern Europe Nano Therapy Market by End User, 2020-2027, (USD Million)
Table 28 Asia Pacific Nano Therapy Market by Technology, 2020-2027, (USD Million)
Table 29 Asia Pacific Nano Therapy Market by Application, 2020-2027, (USD Million)
Table 30 Asia Pacific Nano Therapy Market by End User, 2020-2027, (USD Million)
Table 31 Middle East & Africa Nano Therapy Market by Technology, 2020-2027, (USD Million)
Table 32 Middle East & Africa Nano Therapy Market by Application, 2020-2027, (USD Million)
Table 33 Middle East & Africa Nano Therapy Market by End User, 2020-2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Nano Therapy Market
Figure 3 Segmentation Market Dynamics for Nano Therapy Market
Figure 4 Global Nano Therapy Market Share, by Technology 2020
Figure 5 Global Nano Therapy Market Share, by Application 2020
Figure 6 Global Nano Therapy Market Share, by End Users, 2020
Figure 7 Global Nano Therapy Market Share, by Region, 2020
Figure 8 North America Nano Therapy Market Share, by Country, 2020
Figure 9 Europe Nano Therapy Market Share, by Country, 2020
Figure 10 Asia Pacific Nano Therapy Market Share, by Country, 2020
Figure 11 Middle East & Africa Nano Therapy Market Share, by Country, 2020
Figure 12 Global Nano Therapy Market: Company Share Analysis, 2020 (%)
Figure 13 Smith and Nephew: Key Financials
Figure 14 Smith and Nephew: Segmental Revenue
Figure 16 Smith and Nephew: Geographical Revenue
Figure 17 Selecta Biosciences, Inc..: Key Financials
Figure 18 Selecta Biosciences, Inc. Segmental Revenue
Figure 19 Selecta Biosciences, Inc. Geographical Revenue
Figure 20 Sirnaomics, Inc..: Key Financials
Figure 21 Sirnaomics, Inc..: Segmental Revenue
Figure 22 Sirnaomics, Inc..: Geographical Revenue
Figure 23 Tarveda Therapeutics: Key Financials
Figure 24 Tarveda Therapeutics: Segmental Revenue
Figure 25 Tarveda Therapeutics: Geographical Revenue
Figure 26 DIM: Key Financials
Figure 27 DIM: Segmental Revenue
Figure 28 DIM: Geographical Revenue
Figure 29 CytImmune Science, Inc.: Key Financials
Figure 30 CytImmune Science, Inc.: Segmental Revenue
Figure 31 CytImmune Science, Inc.: Geographical Revenue
Figure 32 Luna NanoBio Corporation: Key Financials
Figure 33 Luna NanoBio Corporation: Segmental Revenue
Figure 34 Luna NanoBio Corporation: Geographical Revenue
Figure 35 Others